Dec 06 2025
MLTX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
Gunnison Copper marks breakthrough with first Nuton-processed copper – ICYMI
MRX DEADLINE MONDAY: ROSEN, A LEADING LAW FIRM, Encourages Marex Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - MRX
CNN Got Snubbed In The Netflix-WBD Deal—Why That's Ultimately A Good Thing
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Is LULU a Buy Right Now?
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LRN
AVTR DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
Could Buying High-Yield Altria Today Set You Up for Life?
DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
2 Top Dividend Stocks to Buy in December
Here's Why 2026 Could Be a Huge Year for Rocket Lab
Aftermath Silver boosts Berenguela project resource - ICYMI
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel's Opportunity in Relapsed or Refractory Multiple Myeloma
JHX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - JHX
Should You Invest in Beyond Meat Stock?
How would the Netflix-Warner Bros. deal reshape Hollywood?
This 9% Dividend Profits When Gen Z Spends Their Paycheck
How Good Has PG Stock Actually Been?
How Good Has MCD Stock Actually Been?
Here Are My Top 3 Quantum Computing Stocks to Buy in December
Why Tesla stock is primed for a ‘face-ripping' rally
Nio Stock Sank Nearly 25% Last Month. Is It a Buy Now?
Best Stock to Buy Right Now: Sirius XM vs. Lululemon
Why Investors Shouldn't Worry About Soapstone Management Liquidating Its $7 Million Saia Position
MLTX 9-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
Tech Corner: INTC Tailwinds & Headwinds After 2025 Turnaround
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
Utility Stocks Are Rebounding. Here Are 3 That Could Continue to Soar In 2026.
Digi Power X rolls out ARMS technology at Alabama site - ICYMI
What Is 1 of the Best Artificial Intelligence Stocks to Buy Now?
Worthington Steel Issues Statement Regarding Klöckner & Co SE
Should Investors Follow Advent International's Lead as it Dumps $153 Million of First Watch Restaurant Group Stock?
4 Things to Watch With DECK Stock in 2026
Flat Like A Lake
77% of Older Americans Say the 2026 Social Security COLA Is Not Enough—Here's What You Can Do About It
The Tools Every Marine Must Master Before Deployment
Why Retiring Early Is Hard Even When You Can Afford It
EUR/USD Forecast – Fed Pivot and Eurozone Stability Signal Breakout Toward 1.22
Prediction: UnitedHealth Group Stock Will Soar in 2026
Armada Hoffler Properties: Turning Bullish On The Preferred Stock Again
Why Shares of Nano Nuclear Energy Stock Collapsed Last Month
Century Lithium CEO discusses rare earth recovery success - ICYMI
Forget Rigetti Computing and Buy This Safer Quantum Stock Instead
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of The Wildermuth Fund
Here's How CZR Stock Could Up the Ante in 2026
2 Artificial Intelligence Stocks That Can Have Their Nvidia Moment in 2026
Is VOO + QQQ the Ultimate Retirement Formula?
Comparing Two of the Top Buy-and-Hold ETFs for Retail Investors: QQQ vs. VOO
UBS Swiss Franc Forecast: GBP/CHF Hits Target, USD/CHF Falls, EUR/CHF Firms
Rabobank Pound to Euro Forecast: GBP to Drift Lower to 1.124 Against EUR in 2026
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
Better Energy Stock: Oklo vs. Centrus Energy
LiberNovo kommt mit Omni nach Europa - dem ergonomischen Stuhl der nächsten Generation, den Sie jetzt bestellen können
LiberNovo débarque en Europe avec Omni - la chaise ergonomique de nouvelle génération que vous pouvez commander dès maintenant
LiberNovo Goes Global: New Markets & A Vision for Healthy Workspaces
Amazon's new frontiers: Robotaxis, ultrafast deliveries, AI teammates
ServiceTitan Q3: AI Offerings Set To Drive Strong Growth Ahead
Evaluating VST Stock's Actual Performance
FLY Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of January 12, 2026 Deadline in Securities Fraud Class Action Lawsuit Against Firefly Aerospace Inc. (FLY)
Why Bloom Energy Stock Sank 17.3% In November
Can Home Depot (HD) Stock Rebound in 2026?
Here's Why Shares in This Nvidia Partner Soared This Week
Credit Agricole Euro to Dollar Forecast: EUR/USD at 1.10 by End-2026, Early 2027
12 Years With Zero Gains: Can Your Retirement Plan Survive A 'Lost Decade?'
'Terrifying': Why U.S. senator in top intel post wants more spying on Chinese companies
SFM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sprouts Farmers Market, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
Here's the Smartest Way to Invest in the S&P 500 in December
Nextech3D.ai to reacquire ARway in strategic move – ICYMI
Netflix Doubled Your Money in 12 Months After Years of Lagging the Market
4 Outsized Dividends From 4 Small Cap Stocks
Why Apple's Momentum Isn't Accidental
Coinbase executive talks crypto regulation, Clarity Act, stablecoins
Cannabis REITs to Watch This December
Blockmate Ventures' Hivello secures quantum future with Naoris deal - ICYMI
PRGO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Can GoPro (GPRO) Stock Keep Its Recovery Effort Alive in 2026?
WPP DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages WPP plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - WPP
Regeneron's experimental therapy combo effective in untreated cancer patients
Science Applications International: Growing Margins And Robust Return On Equity Signal Strength
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
SES AI: Record Revenues For Q3 2025 Driven By Sales From UZ Energy
CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline
Up 96% in 2025, This Stock Will Be Added to the S&P 500 on Dec. 22
MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline
USA Rare Earth Vs MP Materials: Which Rare-Earth Play Is Worth Your Risk?
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
PayPal's Gloom Is Overdone: Prepare For The 2026 Comeback Story
DSU: Vulnerable To The Uncertainty Of Interest Rates
Incyte: Buy At This Inflection Point
Constellation Holds Margin Lead as Vistra Expands With Gas Plants and Buybacks
Viking Therapeutics: Prepping For A Critical 2026
Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue
Risk Disclosure:Derivatives are traded over-the-counter on margin, which means they carry a high level of risk and there is a possibility you could lose all of your investment. These products are not suitable for all investors. Please ensure you fully understand the risks and carefully consider your financial situation and trading experience before trading. Seek independent financial advice if necessary before opening an account with BCR.
BCR Co Pty Ltd (Company No. 1975046) is a company incorporated under the laws of the British Virgin Islands, with its registered office at Trident Chambers, Wickham’s Cay 1, Road Town, Tortola, British Virgin Islands, and is licensed and regulated by the British Virgin Islands Financial Services Commission under License No. SIBA/L/19/1122.
Open Bridge Limited (Company No. 16701394) is a company incorporated under the Companies Act 2006 and registered in England and Wales, with its registered address at Kemp House, 160 City Road, London, City Road, London, England, EC1V 2NX. This entity acts solely as a payment processor and does not provide any trading or investment services.